-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $57

Benzinga·07/30/2026 15:08:30
Listen to the news
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $62 to $57.